CBD is not converted to THC in rats: A framework interpretation and discussion

Warning

This publication doesn't include Faculty of Sports Studies. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

VACEK Jan PAPOUSKOVA Barbora HOLCOVÁ POLANSKÁ Hana HÖNIGOVÁ Kateřina STORCH Jan BABULA Petr MASAŘÍK Michal

Year of publication 2021
Type Article in Periodical
Magazine / Source European Neuropsychopharmacology
MU Faculty or unit

Faculty of Medicine

Citation
Web https://www.sciencedirect.com/science/article/pii/S0924977X21001917?via%3Dihub
Doi http://dx.doi.org/10.1016/j.euroneuro.2021.04.003
Keywords CBD; THC; rats
Description Cannabidiol (CBD) is a non-psychotropic exogenous cannabinoid that is an active component in a number of topical and oral preparations. The pharmacological potential of CBD is determined by its anti-inflammatory and immuno- or neuromodulatory activities. This natural terpenoid is widely used today, and therefore more attention is now paid to examining its safety after the administration of high doses (Epidiolex) and also after low-dose chronic exposure, e.g. in the form of food supplements. CBD is therefore a molecule that has recently gained a great deal of scientific interest, both at the level of basic research and industrial development.

You are running an old browser version. We recommend updating your browser to its latest version.

More info